17 January 2017
Vol 10, Issue 462

About The Cover

Cover image expansion

Online Cover This week features a Research Article that describes antagonistic antibodies targeting the receptor TNFR2 that decrease the survival of ovarian cancer cells and tumor-associated regulatory T cells. The image shows the structure of ligand-bound TNFR2 with the antibody binding sites in red. [Image: Eva Vanamee, Immunobiology Department, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA]